The clearance expands its existing label from patients aged 4 to 7 years to patients aged 4 to under 13 years.

FDA-cleared CureSight™ therapy now reimbursed by Elevance Health, expanding access to effective digital treatment for lazy ...

Visual acuity gradually improved for up to 5 years in patients with amblyopia, including adults, who were treated with ...

Amblyopia, often called “lazy eye,” is a condition where one or both eyes don’t develop normal vision during childhood due to ...

Researchers have found in a new study involving 89 amblyopia patients, including adults, that visual acuity gradually ...

Munich news, health insurance, technology, jobs and other topics for expatriates. The Eye Newspapers covers daily news and offers services for foreigners.

In a study published in Advanced Science, researchers from the Institute of Biophysics of the Chinese Academy of Sciences, ...

Luminopia, Inc., a digital health company pioneering a new class of treatments for neuro-visual disorders, today announced that the U.S. Food & Drug Administration (FDA) cleared its amblyopia ...